Danske Bank’s Jazz Pharmaceuticals JAZZ Stock Holding History

Danske Bank’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-400	Closed	-$68K	–	1369
2025 Q4	$68K	Buy	400 +100	+33%	+$15.3K	﹤0.01%	888
2025 Q3	$39.5K	Sell	300 -58	-16%	-$6.96K	﹤0.01%	1064
2025 Q2	$38K	Sell	358 -36,646	-99%	-$3.98M	﹤0.01%	1090
2025 Q1	$4.59M	Buy	37,004 +20,709	+127%	+$2.7M	0.01%	554
2024 Q4	$2.01M	Sell	16,295 -5,656	-26%	-$667K	0.01%	656
2024 Q3	$2.45M	Buy	21,951 +13,051	+147%	+$1.43M	0.01%	624
2024 Q2	$950K	Sell	8,900 -39,058	-81%	-$4.29M	﹤0.01%	784
2024 Q1	$5.78M	Buy	+47,958	New	+$5.87M	0.02%	544

Other funds holding JAZZ

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

VPM

Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

VCM

Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return

Danske Bank's JAZZ Position: Q1 2026 in Review

Danske Bank sold out of Jazz Pharmaceuticals (JAZZ) in Q1 2026, closing a stake of 400 shares — an estimated $68K sold.

Danske Bank first reported a position in JAZZ in Q1 2024 and held it in 8 quarters. The position peaked at $5.78M in Q1 2024. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.

Danske Bank reported no remaining Jazz Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
Danske Bank sold 400 Jazz Pharmaceuticals shares in Q1 2026, an estimated $68K.
Danske Bank first reported a position in Jazz Pharmaceuticals in Q1 2024 and held it in 8 quarters.
Danske Bank's Jazz Pharmaceuticals position peaked at $5.78M in Q1 2024.
570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.

Based on Danske Bank's 13F filing for Q1 2026, filed 12 May 2026.